公开(公告)号：US20250084158A1

公开(公告)日：2025-03-13

申请号：US18580552

申请日：2022-07-20

Applicant: ABL BIO INC.

Inventor： Eunsil SUNG ,  Junga KWON ,  Youngkwang KIM ,  Juhee KIM ,  Kyungjin PARK ,  Sumyeong PARK ,  Byungje SUNG ,  Byeongmin YOO ,  Bora LEE ,  Suyoun LEE ,  Shinai LEE ,  Yangsoon LEE ,  Eunhee LEE ,  Yangmi LIM ,  Jaehyoung JEON ,  Jinwon JUNG

IPC: C07K16/24 ,  A61K39/00 ,  A61P35/00 ,  C07K16/28

Abstract: Provided are anti-CLL-1 antibodies and uses thereof, according to the anti-CLL-1 antibody of one aspect, it can bind to CLL-1 with high binding affinity, and can cause activation of T cells, thus it can be used effectively for preventing or treating the cancer expressing CLL-1.